Last reviewed · How we verify
GR1802 injection-1
At a glance
| Generic name | GR1802 injection-1 |
|---|---|
| Also known as | Xeligekimab |
| Sponsor | Zheng Liu ENT |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis. (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |